Cited by 686Menopause: Health Impacts and TreatmentsEstrogen and related hormone effectsSexual function and dysfunction studies

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Effects of Estrogen plus Progestin on Health-Related Quality of Life

Open access

Hays, Jennifer, Ockene, Judith K., Brunner, Robert L., Kotchen, Jane M., Manson, JoAnn E., Patterson, Ruth E., Aragaki, Aaron K., Shumaker, Sally A., Brzyski, Robert G., LaCroix, Andrea Z., Granek, Iris A., Valanis, Barbara G.·2003·New England Journal of Medicine

DOI 10.1056/nejmoa030311

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The Women's Health Initiative (WHI) and other clinical trials indicate that significant health risks are associated with combination hormone use. Less is known about the effect of hormone therapy on health-related quality of life. METHODS: The WHI randomly assigned 16,608 postmenopausal women 50 to 79 years of age (mean, 63) with an intact uterus at base line to estrogen plus progestin (0.625 mg of conjugated equine estrogen plus 2.5 mg of medroxyprogesterone acetate, in 8506 women) or placebo (in 8102 women). Quality-of-life measures were collected at base line and at one year in all women and at three years in a subgroup of 1511 women. RESULTS: Randomization to estrogen plus progestin resulted in no significant effects on general health, vitality, mental health, depressive symptoms, or sexual satisfaction. The use of estrogen plus progestin was associated with a statistically significant but small and not clinically meaningful benefit in terms of sleep disturbance, physical functioning, and bodily pain after one year (the mean benefit in terms of sleep disturbance was 0.4 point on a 20-point scale, in terms of physical functioning 0.8 point on a 100-point scale, and in terms of pain 1.9 points on a 100-point scale). At three years, there were no significant benefits in terms of any quality-of-life outcomes. Among women 50 to 54 years of age with moderate-to-severe vasomotor symptoms at base line, estrogen and progestin improved vasomotor symptoms and resulted in a small benefit in terms of sleep disturbance but no benefit in terms of the other quality-of-life outcomes. CONCLUSIONS: In this trial in postmenopausal women, estrogen plus progestin did not have a clinically meaningful effect on health-related quality of life.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa030311

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Untitled work
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
National Institute of Mental Health Diagnostic Interview Schedule: Its History, Characteristics, and Validity
Robins, L. N. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780290015001 · Cited by 5,219
The rand 36‐item health survey 1.0
Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993) · Health Economics · doi:10.1002/hec.4730020305 · Cited by 2,971
Untitled work
(1987) · PubMed · Cited by 2,657
Design of the Women’s Health Initiative Clinical Trial and Observational Study
The Women’s Health Initiative Study Group (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,580

Flagged first, then by citations

Show all 36 references

Research works printed but not linked: 2

FDA approves new labels for estrogen and estrogen with progestin therapies for postmenopausal women following review of Women's Health Initiative data. Rockville, Md.: Food and Drug Administration, January 8, 2003.
Teng EL, 1987, J Clin Psychiatry, 48, 314

Sorted by citations

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C. C., Rizzoli, R., & Reginster, J. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,993
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M. L. S., Lane, D. S., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,871
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
The Medicalization of Society
Conrad, P. (2007) · Johns Hopkins University Press eBooks · doi:10.56021/9780801885846 · Cited by 1,448
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., POTTER, J. F., Sever, P. S., & Thom, S. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001683 · Cited by 1,268
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density The Women's Health Initiative Randomized Trial
Cauley, J. A. (2003) · JAMA · doi:10.1001/jama.290.13.1729 · Cited by 1,229
Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women
Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays-Grudo, J., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2663 · Cited by 939
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
The North American Menopause Society (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31824b970a · Cited by 787
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. А., Burlet, N., Cooper, C. C., Delmas, P. D., Reginster, J., Borgström, F., & Rizzoli, R. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0560-z · Cited by 796
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N. F., Braunstein, G. D., Burger, H., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 687
Hormone therapy for preventing cardiovascular disease in post-menopausal women
Boardman, H. M., Hartley, L., Eisinga, A., Main, C., Roqué i Figuls, M., Bonfill Cosp, X., Gabriel Sanchez, R., & Knight, B. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002229.pub4 · Cited by 612
Randomized controlled trial of yoga and exercise in multiple sclerosis
Oken, B., Kishiyama, S., Zajdel, D., Bourdette, D., Carlsen, J., Haas, M., Hugos, C. L., Kraemer, D., Lawrence, J., & Mass, M. (2004) · Neurology · doi:10.1212/01.wnl.0000129534.88602.5c · Cited by 610
Long term hormone therapy for perimenopausal and postmenopausal women
Farquhar, C. M., Marjoribanks, J., Lethaby, A. E., Suckling, J. A., & Okonkwo, Q. L. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004143.pub2 · Cited by 587
International Union of Pharmacology. LXIV. Estrogen Receptors
Dahlman-Wright, K., Cavailles, V., Fuqua, S. A., Jordan, V. C., Katzenellenbogen, J. A., Korach, K. S., Maggi, A., Muramatsu, M., Parker, M. G., & Gustafsson, J.-Å. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.8 · Cited by 583
Dietary phytoestrogens and health
Cornwell, T. (2004) · Phytochemistry · doi:10.1016/j.phytochem.2004.03.005 · Cited by 530
Menopause
Davis, S. R., Lambrinoudaki, I. V., Lumsden, M.-A., Mishra, G. D., Pal, L., REES, M. C. P., Santoro, N. F., & Simoncini, T. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.4 · Cited by 506
A Review and Update of Mechanisms of Estrogen in the Hippocampus and Amygdala for Anxiety and Depression Behavior
Walf, A. A., & Frye, C. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301067 · Cited by 477
Long-term hormone therapy for perimenopausal and postmenopausal women
Marjoribanks, J., Farquhar, C. M., Roberts, H., Lethaby, A. E., & Lee, J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004143.pub5 · Cited by 447
Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review
Utian, W. H. (2005) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-3-47 · Cited by 411
A Decade of Reversal: An Analysis of 146 Contradicted Medical Practices
Prasad, V., Vandross, A., Toomey, C., Cheung, M., Rho, J., Quinn, S., Chacko, S. J., Borkar, D., Gall, V., Selvaraj, S., et al. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.05.012 · Cited by 381
Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women.
Kravitz, H., Zhao, X., Bromberger, J., Gold, E., Hall, M., Matthews, K., & Sowers, M. (2008) · Sleep · doi:10.5665/sleep/31.7.979 · Cited by 400
Postmenopausal syndrome
Dalal, P., & Agarwal, M. (2015) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.161483 · Cited by 382
Estrogen and skin: The effects of estrogen, menopause, and hormone replacement therapy on the skin
Hall, G. K., & Phillips, T. J. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.08.039 · Cited by 337
Sexual dysfunction in men and women with endocrine disorders
Bhasin, S., Enzlin, P., Coviello, A. D., & Basson, R. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60280-3 · Cited by 319
Menopausal Symptoms and Treatment-Related Effects of Estrogen and Progestin in the Womenʼs Health Initiative
Barnabei, V. M., Cochrane, B. B., Aragaki, A. K., Nygaard, I. E., Williams, R. S., McGovern, P. G., Young, R. L., Wells, E. C., OʼSullivan, M. J., Chen, B. H., et al. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000158120.47542.18 · Cited by 318
Steroid hormones and neurosteroids in normal and pathological aging of the nervous system
Schumacher, M., Weill‐Engerer, S., Lière, P., Robert, F., Franklin, R. J. M., García‐Segura, L. M., Lambert, J. J., Mayo, W., Melcangi, R. C., Párducz, Á., et al. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.004 · Cited by 299
Sleep and Sleep Disorders in the Menopausal Transition
Baker, F. C., Lampio, L., Saaresranta, T., & Polo‐Kantola, P. (2018) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2018.04.011 · Cited by 321
Long term hormone therapy for perimenopausal and postmenopausal women
Marjoribanks, J., Farquhar, C. M., Roberts, H., & Lethaby, A. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004143.pub4 · Cited by 286
Health-related quality of life after osteoporotic fractures
Hallberg, I., Rosenqvist, A.-M., Kartous, L., L�fman, O., Wahlstr�m, O., & Toss, G. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1622-5 · Cited by 274
Sex differences in psychopathology: of gonads, adrenals and mental illness
Solomon, M. B., & Herman, J. P. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.033 · Cited by 272
Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Urolithins, Ellagic Acid-Derived Metabolites Produced by Human Colonic Microflora, Exhibit Estrogenic and Antiestrogenic Activities
Larrosa, M., González‐Sarrías, A., García‐Conesa, M., Tomás-Barberán, F. A., & Espı́n, J. C. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0527403 · Cited by 261
Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial
Morrison, M. F., Kallan, M. J., Have, T. T., Katz, I. R., Tweedy, K., & Battistini, M. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.011 · Cited by 245
The Effects of Flaxseed Dietary Supplement on Lipid Profile, Bone Mineral Density, and Symptoms in Menopausal Women: A Randomized, Double-Blind, Wheat Germ Placebo-Controlled Clinical Trial
Dodin, S., Lemay, A., Jacques, H., Légaré, F., Forest, J.-C., & Mâsse, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1148 · Cited by 244
Testosterone for peri and postmenopausal women
Somboonporn, W., Bell, R. J., & Davis, S. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004509.pub2 · Cited by 248
Potential Mechanisms of Estrogen Quinone Carcinogenesis
Bolton, J. L., & Thatcher, G. R. J. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700191p · Cited by 242
Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy
Veronesi, U., Maisonneuve, P., Rotmensz, N., Bonanni, B., Boyle, P., Viale, G., Costa, A., Sacchini, V., Travaglini, R., D’Aiuto, G., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk154 · Cited by 241
Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women
Whelan, T. J., Goss, P. E., Ingle, J. N., Pater, J. L., Tu, D., Pritchard, K. I., Liu, S., Shepherd, L. E., Palmer, M. K., Robert, N. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.181 · Cited by 239
Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention
Land, S. R., Wickerham, D. L., Costantino, J. P., Ritter, M. W., Vogel, V. G., Lee, M., Pajon, E. R., Wade, J. L., Dakhil, S. R., Lockhart, J. B., et al. (2006) · JAMA · doi:10.1001/jama.295.23.joc60075 · Cited by 237
Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination
Schumacher, M., Guennoun, R., Robert, F., Carelli, C., Gago, N., Ghoumari, A. M., Deniselle, M. C. G., González, S. L., Ibanez, C., Labombarda, F., et al. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.03.007 · Cited by 236
Women's sleep in health and disease
Dzaja, A., Arber, S., Hislop, J., Kerkhofs, M., Kopp, C., Pollmächer, T., Polo‐Kantola, P., Skene, D. J., Stenuit, P., Tobler, I., et al. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.05.008 · Cited by 227
Population-based multidimensional assessment of older people in UK general practice: a cluster-randomised factorial trial
FLETCHER, A. E., Price, G. M., Ng, E. S. W., Stirling, S., Bulpitt, C. J., Breeze, E., Nunes, M., Jones, D. A., Latif, A., Fasey, N. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17353-4 · Cited by 223
Hormone Therapy Prescribing Patterns in the United States
Buist, D. S. M., Newton, K. M., Miglioretti, D. L., Beverly, K., Connelly, M. T., Andrade, S., Hartsfield, C. L., Wei, F., Chan, K. A., & Kessler, L. G. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000143826.38439.af · Cited by 213
Objective Cancer-Related Variables Are Not Associated With Depressive Symptoms in Women Treated for Early-Stage Breast Cancer
Bardwell, W. A., Natarajan, L., Dimsdale, J. E., Rock, C. L., Mortimer, J. E., Hollenbach, K. A., & Pierce, J. P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0081 · Cited by 205
Health related quality of life after combined hormone replacement therapy: randomised controlled trial
Welton, A. J., Vickers, M. R., Kim, J., Ford, D., LAWTON, B. A., Maclennan, A. H., Meredith, S. K., Martin, J., Meade, T. W., & for the WISDOM team (2008) · BMJ · doi:10.1136/bmj.a1190 · Cited by 202
Estrogen increases the number of spinophilin‐immunoreactive spines in the hippocampus of young and aged female rhesus monkeys
Hao, J., Janssen, W. G. M., Tang, Y. C., Roberts, J. A., McKay, H. M., Lasley, B. L., Allen, P. B., Greengard, P., Rapp, P. R., Kordower, J. H., et al. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10837 · Cited by 200
Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study
Suvanto‐Luukkonen, E., Koivunen, R. M., m, H. S., Bloigu, R., Karjalainen, E., llinen, L. H. I. M., & Tapanainen, J. S. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200512010-00006 · Cited by 200
Reduced-Calorie Dietary Weight Loss, Exercise, and Sex Hormones in Postmenopausal Women: Randomized Controlled Trial
Campbell, K. L., Foster‐Schubert, K. E., Alfano, C. M., Wang, C., Wang, C., Duggan, C. R., Mason, C. E., Imayama, I., Kong, A., Xiao, L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.9792 · Cited by 207
Symptom Experience After Discontinuing Use of Estrogen Plus Progestin
Ockene, J. K. (2005) · JAMA · doi:10.1001/jama.294.2.183 · Cited by 200
Evaluation and management of sleep disturbance during the menopause transition
Joffe, H., Massler, A., & Sharkey, K. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0030-1262900 · Cited by 195
Women sleep objectively better than men and the sleep of young women is more resilient to external stressors: effects of age and menopause
BIXLER, E. O., PAPALIAGA, M. N., VGONTZAS, A. N., LIN, H., PEJOVIC, S., KARATARAKI, M., VELA‐BUENO, A., & CHROUSOS, G. P. (2009) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2008.00713.x · Cited by 195
Sexual Desire and Arousal Disorders in Women
Basson, R. J. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp050154 · Cited by 190
Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens
Cappelletti, M., & Wallen, K. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.11.003 · Cited by 181
The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women
Schaap, L. A., Pluijm, S. M. F., Smit, J. H., Van Schoor, N. M., Visser, M., Gooren, L. J. G., & Lips, P. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02315.x · Cited by 168
Sleep problems in midlife and beyond
Polo‐Kantola, P. (2011) · Maturitas · doi:10.1016/j.maturitas.2010.12.009 · Cited by 164
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Schumacher, M., Guennoun, R., Ghoumari, A. M., Massaad, C., Robert, F., El‐Etr, M., Akwa, Y., Rajkowski, K. M., & Baulieu, É.-É. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0050 · Cited by 170
Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women
Gartlehner, G., Patel, S. V., Feltner, C., Weber, R. P., de Long, R., Mullican, K., Boland, E., Lux, L. J., & Viswanathan, M. (2017) · JAMA · doi:10.1001/jama.2017.16952 · Cited by 166
Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With BRCA1/2 Mutations: A Decision Analysis
Armstrong, K., Schwartz, J. S., Randall, T. C., Rubin, S. C., & Weber, B. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.090 · Cited by 161
Sexual function in elderly women: a review of current literature.
Ambler, D. R., Bieber, E. J., & Diamond, M. P. (2012) · PubMed Central · Cited by 155
Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems
Birzniece, V., Bäckström, T. C., Johansson, I., Lindblad, C., Lundgren, P., Löfgren, M., Olsson, T., Ragagnin, G., Taube, M., Türkmen, Ş., et al. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.001 · Cited by 151
The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition
Naftolin, F. N., Taylor, H. S., Karas, R. H., Brinton, E. A., Newman, I., Clarkson, T. B., Mendelsohn, M. E., Løbo, R. A., Judelson, D. R., Nachtigall, L. E., et al. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.02.095 · Cited by 149
Estrogens and non-reproductive behaviors related to activity and fear.
Morgan, M. A., Schulkin, J., & Pfaff, D. (2004) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.11.017 · Cited by 149
Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial
Constantine, G. D., Graham, S. A., Portman, D. J., Rosen, R., & Kingsberg, S. A. (2014) · Climacteric · doi:10.3109/13697137.2014.954996 · Cited by 150
Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women
Aiello, E. J., Yasui, Y., Tworoger, S. S., Ulrich, C. M., Irwin, M. L., Bowen, D. J., Schwartz, R. S., Kumai, C., Potter, J. D., & McTiernan, A. (2004) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000113932.56832.27 · Cited by 145
Effect of Hysterectomy vs Medical Treatment on Health-Related Quality of Life and Sexual Functioning
Kuppermann, M., Varner, R. E., Summitt, R. L., Learman, L. A., Ireland, C. C., Vittinghoff, E., Stewart, A. L., Lin, F., Richter, H. E., Showstack, J. A., et al. (2004) · JAMA · doi:10.1001/jama.291.12.1447 · Cited by 144
Effects of Estrogen Treatment on Expression of Brain-Derived Neurotrophic Factor and cAMP Response Element-Binding Protein Expression and Phosphorylation in Rat Amygdaloid and Hippocampal Structures
Zhou, J. R., Zhang, H., Cohen, R. S., & Pandey, S. C. (2005) · Neuroendocrinology · doi:10.1159/000088448 · Cited by 137
The relative importance of specific risk factors for insomnia in women treated for early‐stage breast cancer
Bardwell, W. A., Profant, J., Casden, D. R., Dimsdale, J. E., Ancoli‐Israel, S., Natarajan, L., Rock, C. L., Pierce, J. P., & for the Women's Healthy Eating & Living (WHEL) Study Group (2007) · Psycho-Oncology · doi:10.1002/pon.1192 · Cited by 136
Eszopiclone in Patients With Insomnia During Perimenopause and Early Postmenopause: A Randomized Controlled Trial
Soares, C. N., Joffe, H., Rubens, R., Caron, J., Roth, T., & Cohen, L. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000245449.97365.97 · Cited by 135
Acupuncture for menopausal hot flushes
Dodin, S., Blanchet, C., Marc, I., Ernst, E., Wu, T., Vaillancourt, C., Paquette, J., & Maunsell, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007410.pub2 · Cited by 135
Vascular Effects of Phytoestrogens and Alternative Menopausal Hormone Therapy in Cardiovascular Disease
Gencel, V. B., Benjamin, M. M., Bahou, S. N., & Khalil, R. A. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712798995020 · Cited by 134
Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis
Cintrón-López, D., Lipford, M. C., Larrea-Mantilla, L., Spencer‐Bonilla, G., Lloyd, R. M., Gionfriddo, M. R., Gunjal, S., Farrell, A. M., Miller, V. M., & Murad, M. H. (2016) · Endocrine · doi:10.1007/s12020-016-1072-9 · Cited by 133
Postmenopausal hormone therapy: risks and benefits
Rozenberg, S., Vandromme, J., & Antoine, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.17 · Cited by 132
Quality of Life Determinants in Young Women with Turner’s Syndrome after Growth Hormone Treatment: Results of the StaTur Population-Based Cohort Study
Carel, J., Écosse, E., Bastié-Sigeac, I., Cabrol, S., Tauber, M., Léger, J., Nicolino, M. P., Brauner, R., Chaussain, J., & Coste, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1395 · Cited by 132
Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendations
Nelson, H. D., Walker, M., Zakher, B., & Mitchell, J. P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00466 · Cited by 132
Health-related quality of life of women with menopausal hot flushes and night sweats
Ayers, B., & Hunter, M. S. (2012) · Climacteric · doi:10.3109/13697137.2012.688078 · Cited by 128
Lessons Learned From the Women's Health Initiative Trials of Menopausal Hormone Therapy
Rossouw, J. E., Manson, J. E., Kaunitz, A. M., & Anderson, G. L. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31827a08c8 · Cited by 125
A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: Effect on mood, cognition and quality of life
Almeida, O. P., Lautenschlager, N. T., Vasikaran, S. D., Leedman, P. J., Gelavis, A., & Flicker, L. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.12.012 · Cited by 123
Effects of Conjugated Equine Estrogen on Health-Related Quality of Life in Postmenopausal Women With Hysterectomy: Results From the Women’s Health Initiative Randomized Clinical Trial
Brunner, R. L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.17.1976 · Cited by 122
EFFICACY OF ESTRADIOL IN PERIMENOPAUSAL DEPRESSION: SO MUCH PROMISE AND SO FEW ANSWERS
Rubinow, D., Johnson, S., Schmidt, P. J., Girdler, S., & Gaynes, B. (2015) · Depression and Anxiety · doi:10.1002/da.22391 · Cited by 79
Insomnia and menopause: a narrative review on mechanisms and treatments
Proserpio, P., Marra, S., Campana, C., Agostoni, E. C., Palagini, L., Nobili, L., & Nappi, R. E. (2020) · Climacteric · doi:10.1080/13697137.2020.1799973 · Cited by 120
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women’s Health Initiative Randomized Trial
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M. L. S., Lane, D. S., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000093674.44946.d6 · Cited by 119
Hormone therapy and cognitive function
Maki, P. M., & Sundermann, E. E. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp022 · Cited by 117
Postmenopausal Hormones — Therapy for Symptoms Only
Grady, D. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmp030038 · Cited by 116
Quality of life in climacteric women
Schneider, H. P. G., & Birkhäuser, M. (2017) · Climacteric · doi:10.1080/13697137.2017.1279599 · Cited by 115
Effects of Ultra–Low-Dose Transdermal Estradiol on Cognition and Health-Related Quality of Life
Yaffe, K. S., Vittinghoff, E., Ensrud, K. E., Johnson, K., Diem, S. J., Hanes, V., & Grady, D. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.945 · Cited by 115
Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review
Dietel, M., Lewis, M. A., & Shapiro, S. (2005) · Human Reproduction · doi:10.1093/humrep/dei043 · Cited by 114
The Women's Health Initiative: Lessons Learned
Prentice, R. L., & Anderson, G. L. (2008) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.29.020907.090947 · Cited by 114
The age of menopause and the menopause transition in a multiracial population: a nation-wide Singapore study
Loh, F.-H., Khin, L., Saw, S., Lee, J. J. M., & Gu, K. (2005) · Maturitas · doi:10.1016/j.maturitas.2004.11.004 · Cited by 113
Validation of the Women’s Health Initiative Insomnia Rating Scale in a Multicenter Controlled Clinical Trial
Levine, D. W., Dailey, M. E., Rockhill, B., Tipping, D., Naughton, M. J., & Shumaker, S. A. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000151743.58067.f0 · Cited by 112
Disorders Associated With Acute Rapid and Severe Bone Loss
Epstein, S., Inzerillo, A. M., Caminis, J. N., & Zaidi, M. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2083 · Cited by 110
Hormone therapy for sexual function in perimenopausal and postmenopausal women
Nastri, C. O., Lara, L. A. D. S., Ferriani, R. A., Rosa-e-Silva, A. C. J., Figueiredo, J. B., & Martins, W. P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009672.pub2 · Cited by 109
A comparative review of the risks and benefits of hormone replacement therapy regimens
Warren, M. P. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.09.033 · Cited by 107
The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI
Nappi, R. E., & Davis, S. R. (2012) · Climacteric · doi:10.3109/13697137.2012.657589 · Cited by 106
A randomized, controlled pilot study of acupuncture treatment for menopausal hot flashes
Avis, N. E., Legault, C., Coeytaux, R. R., Pian-Smith, M. C. M., Shifren, J. L., Chen, W., & Valaskatgis, P. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31816d5b03 · Cited by 105
Assessment and treatment of hot flushes and menopausal mood disturbance
Joffe, H., Soares, C. N., & Cohen, L. S. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00045-5 · Cited by 105
The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials
Alexander, J. L., Kotz, K. J., Dennerstein, L., Kutner, S. J., Wallen, K., & Notelovitz, M. (2004) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000142887.31811.97 · Cited by 100
Neuroendocrine Regulation of Feminine Sexual Behavior: Lessons from Rodent Models and Thoughts About Humans
Blaustein, J. D. (2007) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093556 · Cited by 101
In vitro estrogenic activity of Achillea millefolium L.
Innocenti, G., Vegeto, E., Dall’Acqua, S., Ciana, P., Giorgetti, M., Agradi, E., Sozzi, A., Fico, G., & Tomé, F. (2006) · Phytomedicine · doi:10.1016/j.phymed.2006.05.005 · Cited by 101
Effects of postmenopausal hormone therapy on rheumatoid arthritis: The women's health initiative randomized controlled trials
Walitt, B. T., Pettinger, M. B., Weinstein, A., Katz, J. D., Torner, J. C., Wasko, M. C., Howard, B. V., & Women's Health Initiative Investigators (2008) · Arthritis Care & Research · doi:10.1002/art.23325 · Cited by 98

Authors: Hays, J., Ockene, J. K., Brunner, R. L., Kotchen, J. M., Manson, J. E., Patterson, R. E., Aragaki, A. K., Shumaker, S. A., Brzyski, R. G., LaCroix, A. Z., Granek, I. A., & Valanis, B. G.
Affiliations: University of Massachusetts Chan Medical School (US)
University of Nevada, Reno (US)
Medical College of Wisconsin (US)
Brigham and Women's Hospital (US)
Fred Hutch Cancer Center (US)
Wake Forest University Health Sciences (US)
The University of Texas at San Antonio Health Science Center (US)
State University of New York (US)
Kaiser Permanente Center for Health Research (US)
ORCID: Ockene, Judith K.
Brunner, Robert L.
Manson, JoAnn E.
Patterson, Ruth E.
Aragaki, Aaron K.
LaCroix, Andrea Z.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2003-05-08
Volume: 348
Issue: 19
Pages: 1839-1854
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa030311
OpenAlex: W2110502449
Cited by: 686
References: 36
Citations by year: 2026: 6 · 2025: 14 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 11 · 2018: 12 · 2017: 9 · 2016: 17 · 2015: 15 · 2014: 18 · 2013: 23 · 2012: 25
FWCI: 66.22
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
eScholarship@UMassChan (submittedVersion)
eScholarship (California Digital Library) (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
Keywords: estrogen plus progestin, hormone therapy, health-related quality of life, postmenopausal women, conjugated equine estrogens, medroxyprogesterone acetate, vasomotor symptoms, sleep disorders, physical function, bodily pain, depressive symptoms, sexual satisfaction, Women's Health Initiative
MeSH terms: Aged, Cognition, Depression, Estrogens, Female, Health Status, Humans, Mental Health, Middle Aged, Progestins, Quality of Life, Sexual Behavior, Sleep Wake Disorders, Estrogen Replacement Therapy, Linear Models, Hot Flashes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effects of Estrogen plus Progestin on Health-Related Quality of Life

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks